Peter Schmid was appointed as Chair in Cancer Medicine at Barts Cancer Institute, Queen Mary University London, in 2013. He is Clinical Director of the Breast Cancer Centre at the St. Bartholomew Cancer Centre and Honorary Consultant Medical Oncologist at Barts Hospital. Prof. Schmid’s specialist interests are breast cancer, cancer immune therapy and early drug development. His research interests lie in stratified cancer medicine utilising novel biomarkers and innovative, biomarker-driven clinical trial strategies. He has successfully led more than 20 national/international academic clinical studies, and is principal investigator of two ongoing, prospective international biomarker studies on predictive epigenetics from circulating tumour DNA.